LOADING ...

big pharma's posts - English uPOST

Mar 26, 2020. 12 comments

Pharma Giant Gilead Retracts Request FDA Extend Monopoly Status on Experimental Covid-19 Drug

Pharma Giant Gilead Retracts Request FDA Extend Monopoly Status on Experimental Covid-19 Drug

Pharmaceutical giant Gilead Sciences on Wednesday retracted its effort to score extended monopoly rights and tax breaks on its antiviral drug remdesivir, which scientists are evaluating as a possible treatment in the novel coronavirus pandemic.

Per the Intercept, on Monday the Food and Drug Administration awarded Gilead “orphan” drug status for remdesivir, which would give it a marketing...

12 Comments

Mar 02, 2020. 20 comments

Many States Still Can't Test Locally For Coronavirus Despite Promises From Trump Regime

Many States Still Can't Test Locally For Coronavirus Despite Promises From Trump Regime

Alex Azar, secretary of the Department of Health and Human Services (HHS), appeared on the Sunday political TV shows this weekend to reassure Americans that federal health authorities were prepared to tackle the coronavirus crisis, which has so far sickened at least 89 people in 12 states across the U.S. and killed two people in Washington. New York and Florida reported their first cases...

20 Comments

Feb 29, 2020. 23 comments

A Coronavirus Vaccine Should Be Free, Not 'Affordable'

A Coronavirus Vaccine Should Be Free, Not 'Affordable'

The Trump Administration’s early reaction to the outbreak of a new coronavirus that’s near certain to hit the U.S. hard hasn’t been great , to put it lightly.

One clear example of that this week was Health and Human Services Secretary Alex Azar’s initial refusal to promise that an eventual vaccine for the virus wouldn’t be out of reach financially for the public, arguing they couldn’t “control...

23 Comments

Tom McKay Tom McKay Jan 03, 2020. 15 comments

Big Pharma Continues New Year's Tradition of Squeezing U.S. Sick for Every Last Dime

Big Pharma Continues New Year's Tradition of Squeezing U.S. Sick for Every Last Dime

Pharmaceutical giants celebrated the dawn of 2020 in the best way they know how: jacking up the prices of drugs for people in the U.S. that need them.

According to a report by Reuters, research by analysts at 3 Axis Advisors shows that firms including Pfizer Inc., GlaxoSmithKline PLC, Sanofi SA, Bristol-Myers Squibb Co., Gilead Sciences Inc., and Biogen Inc. have collectively raised U.S....

15 Comments

Ed Cara Ed Cara Dec 21, 2019. 9 comments

Big Pharma Money Really Does Influence What Doctors Prescribe, Report Finds

Big Pharma Money Really Does Influence What Doctors Prescribe, Report Finds

A new ProPublica report out Friday confirms what many people already suspect about Big Pharma’s influence on health care: Doctors who get money from a pharmaceutical company related to a specific brand name drug are more likely to prescribe that same, often expensive drug to their patients.

It’s no secret that pharmaceutical companies spend plenty of money on doctors and scientists—upwards of

9 Comments

Ed Cara Ed Cara Nov 20, 2019. 17 comments

It's Time to Kick Big Pharma Out of Antibiotics Research, Scientists Argue

It's Time to Kick Big Pharma Out of Antibiotics Research, Scientists Argue

In the wake of recent reports showing that antibiotic-resistant superbugs are on the rise, some scientists in the UK are pushing for a fix that might seem radical. They argue that the research and development of new antibiotics should be taken out of the pharmaceutical industry’s hands and publicly funded on a global scale.

The premise of their argument, which is described in an op-ed...

17 Comments

Matt Novak Matt Novak Jun 06, 2019. 18 comments

Drug Company to Pay Just $15.4 Million Over Doctor Bribery Scandal Involving Medicine That Brings in $1 Billion a Year

Drug Company to Pay Just $15.4 Million Over Doctor Bribery Scandal Involving Medicine That Brings in $1 Billion a Year

Mallinckrodt Pharmaceuticals announced today that the company expects to pay $15.4 million in a settlement with the U.S. Justice Department after allegations that Questcor Pharmaceuticals, which Mallinckrodt acquired in 2014, had bribed doctors and their staff to prescribe an incredibly expensive drug.

Two whistleblowers came forward in April to accuse Questcor of trying to boost profits for...

18 Comments

Matt Novak Matt Novak May 08, 2019. 12 comments

Pharma Companies Will Soon Be Required to List Drug Prices in TV Ads

Pharma Companies Will Soon Be Required to List Drug Prices in TV Ads

TV ads for prescription drugs are already annoying as hell, but those drug ads are about to get even more absurd. The U.S. government will soon require pharmaceutical companies to display the price of medications during every commercial.

Alex Azar, the secretary of Health and Human Services, announced the proposed requirement to the Associated Press in an article published this morning, and it...

12 Comments

Ed Cara Ed Cara Feb 27, 2019. 21 comments

Here Are the Three Dumbest Claims Pharma CEOs Made When Defending Exorbitant Drug Prices

Here Are the Three Dumbest Claims Pharma CEOs Made When Defending Exorbitant Drug Prices

On Tuesday, seven prominent CEOs and leaders of pharmaceutical companies appeared before the Senate Finance Committee at a congressional hearing called to address the industry’s relentless raising of drug prices.

Predictably, the CEOs from Bristol-Myers Squibb, Johnson & Johnson, Merck, Pfizer, Sanofi, AbbVie, and AstraZeneca collectively passed the buck, mostly blaming everyone else for the...

21 Comments

Matt Novak Matt Novak Feb 26, 2019. 19 comments

Big Pharma Gives Big Money to the Senators Who Will Question Drug Company CEOs Today

Big Pharma Gives Big Money to the Senators Who Will Question Drug Company CEOs Today

The CEOs of America’s largest drug companies will testify on Capitol Hill today. But will U.S. senators really hold their feet to the fire after taking so much money from those same drug companies?

Starting at 10:15 am ET (7:15 am PT), the Senate Finance Committee will have the opportunity to question the CEOs of Bristol-Myers Squibb, Johnson & Johnson, Merck, Pfizer, Sanofi, AbbVie, and...

19 Comments

Ed Cara Ed Cara Aug 17, 2018. 8 comments

FDA Finally Approves a Cheaper, Generic Version of the EpiPen

FDA Finally Approves a Cheaper, Generic Version of the EpiPen

A life-saving but increasingly expensive treatment for severe allergic attacks is poised to become cheaper.

On Thursday, the Food and Drug Administration announced its approval of a generic version of the EpiPen and EpiPen Jr sold by pharmaceutical company Mylan. The approval comes in the wake of several scandals involving Mylan’s version, including an ongoing shortage of the drug.

The EpiPen...

8 Comments

Ed Cara Ed Cara Aug 16, 2018. 4 comments

Doctors Aren't Being Candid About the Money They Get From Big Pharma 

Doctors Aren't Being Candid About the Money They Get From Big Pharma 

Physicians who get paid extra by pharmaceutical and medical device companies often aren’t forthcoming about the money in their research papers, according to a study out Wednesday in JAMA Surgery. It found that many of the doctors who receive the most in industry payments only occasionally disclose their potential financial conflicts when publishing relevant research.

The authors behind the new...

4 Comments

Ed Cara Ed Cara Jul 27, 2018. 6 comments

23andMe Is Getting Lots of Money From Big Pharma and Sharing Your Genetic Data

23andMe Is Getting Lots of Money From Big Pharma and Sharing Your Genetic Data

23andMe customers might just play a role in helping create one of Big Pharma’s next blockbuster drugs. On Wednesday, the genetic testing company announced it was entering a partnership with pharmaceutical giant GlaxoSmithKline (GSK) to develop new drugs and therapies. As part of the collaboration, the company will allow GSK to peek at the (voluntarily shared) genetic data of millions of...

6 Comments

Ed Cara Ed Cara Jul 21, 2018. 3 comments

Bayer Will Soon Stop U.S. Sales of Controversial Birth Control Implant Essure

Bayer Will Soon Stop U.S. Sales of Controversial Birth Control Implant Essure

A controversial birth control treatment that is alleged to have harmed thousands of women in the past two decades is finally being phased out completely. On Friday, the pharmacy Bayer announced it would stop selling its Essure birth control implant within the U.S. by December 31 of this year. It follows a similar move by the company to end sales everywhere else in the world, including Europe,...

3 Comments

Ed Cara Ed Cara Jul 13, 2018. 15 comments

Novartis Becomes the Latest Pharma Company to Give Up on Antibiotics Research

Novartis Becomes the Latest Pharma Company to Give Up on Antibiotics Research

Much like climate change, the growing emergence of antibiotic-resistant bacterial superbugs is a ticking time bomb that threatens our very way of life. It’s also a very expensive problem to tackle, and Big Pharma has struggled to find any promising solutions. On Wednesday, yet another major pharmaceutical—the Swiss-based Novartis—announced it is dropping out of the antibiotics game.

Novartis,...

15 Comments

Ed Cara Ed Cara Jul 07, 2018. 3 comments

Report: Doctors Who Recommend Drugs for Approval Often Get Big Pharma Money After

Report: Doctors Who Recommend Drugs for Approval Often Get Big Pharma Money After

The Food and Drug Administration is doing a poor job of making sure the doctors who review drugs for possible approval are free of bias, alleges a new investigative report published this week in Science. Many of these reviewers, while having no clear financial conflicts of interest prior to their work for the FDA, went on to earn paychecks and research funding from the companies whose drugs...

3 Comments

Ed Cara Ed Cara Jun 01, 2018. 18 comments

Ambien Has Some Terrible Side Effects, Even If It Doesn't Make You Racist

Ambien Has Some Terrible Side Effects, Even If It Doesn't Make You Racist

Last night, Soros truther and former hit ABC star Roseanne Barr penned a barrage of tweets attempting to explain some recent racist, paranoid tweets that got her namesake show cancelled. Among the explanations she offered, such as it being Memorial Day, she alluded to tweeting while taking the sleep aid zolpidem, commonly sold under the brand name Ambien.

Barr eventually deleted that tweet,...

18 Comments

Matt Novak Matt Novak May 22, 2018. 13 comments

FDA Publicly Shames Drug Companies That Block Generic Meds

FDA Publicly Shames Drug Companies That Block Generic Meds

Today the Food and Drug Administration published a list of pharmaceutical companies accused of bogging down the development of generic drugs. The makers of brand name drugs are constantly putting up obstacles that delay the development of generic medications, according to generics manufacturers, and this new list calls them out. But it remains to be seen whether major drug companies are...

13 Comments

Matt Novak Matt Novak May 21, 2018. 16 comments

Top Lawyer at Novartis Quits After Drug Company's $1.2 Million Payment to the President's Fixer Is Exposed

Top Lawyer at Novartis Quits After Drug Company's $1.2 Million Payment to the President's Fixer Is Exposed

The top lawyer at pharmaceutical company Novartis has announced that he’s leaving the company today. The departure of General Counsel Felix Ehrat comes in the wake of news that Novartis had given $1.2 million to a secret shell company controlled by President Trump’s personal lawyer and “fixer,” Michael Cohen. Novartis claims it got nothing in return for the money.

“Although the contract was...

16 Comments

Ed Cara Ed Cara Jan 22, 2018. 20 comments

Fed-Up Hospitals Are Starting Their Own Drug Company so They Can Lower Generic Drug Prices

Fed-Up Hospitals Are Starting Their Own Drug Company so They Can Lower Generic Drug Prices

A coalition of U.S. hospitals has decided to take matters into its own hands in the face of ever-rising drug prices: The group is going to start its own drug company to compete with big pharma.

On Friday, several of the largest hospital systems in the country announced their plan to pool together their resources in order to create a not-for-profit company that will make and sell certain...

20 Comments

Language